CHANTIX has also been studied in postmarketing trials including (1) a trial conducted in patients with chronic obstructive pulmonary disease (COPD), (2) a trial conducted in generally healthy patients (similar to those in the premarketing studies) in which they were allowed to select a quit date between days 8 and 35 of treatment (alternative quit date instruction trial), (3) a trial conducted in patients who did not succeed in stopping smoking during prior CHANTIX therapy, or who relapsed after treatment (re-treatment trial), (4) a trial conducted in patients with stable cardiovascular disease, (5) a trial conducted in patients with stable schizophrenia or schizoaffective disorder, (6) a trial conducted in patients with major depressive disorder, (7) a postmarketing neuropsychiatric safety outcome trial in patients without or with a history of psychiatric disorder, and (8) a trial in patients who were not able or willing to quit abruptly and who were instructed to quit gradually (gradual approach to quitting smoking trial)

Feliza Tolosa, 34-year-old mother to 5 children, said she cant live without it
This magical holiday mixture delights with notes of allspice, cinnamon, and vanilla, reminiscent of freshly baked holiday cookies
"They want to hold them accountable and let a jury make a decision as to what is proper in this case." One of the plaintiffs, Tony Gwynn Jr., said his father never smoked or drank, and that he didn't know the dangers of chewing smokeless tobacco when he first started using the product
Zyn is part of a new wave of smokeless tobacco products thats shaking up the market